Summary: Ochratoxin A is a mycotoxin produced by Aspergillus ochraceus and is a natural contaminant of moldy food. Ochratoxin A has a number of toxic effects, some of which may be related to the changes in the cell membrane. We measured the activities of 5 pancreatic, membrane bound enzymes in female Fisher rats that were given low oral doses of ochratoxin A (120 Mg/kg body weight per day) during 20-35 days. The amount of toxin corresponds to 1.5 mg/kg in the feed, daily. These doses are in the range of natural contamination found in feed. The enzymes studied were alanine aminopeptidase, alkaline phosphatase, ecto-Ca 
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might seriously impair cell membrane integrity, and produce structural and functional changes eventually leading to cellular necrosis (11) .
Ochratoxin A affects carbohydrate metabolism in rats, producing an increase in blood glucose and a concomitant decrease in glycogen in liver. The increase in the blood glucose level was accompanied by decreased levels of insulin during ochratoxin A treatment of rats (2) . Induction of hyperglycaemia associated with hypoinsulinaemia were also produced with other mycotoxins like terreic acid and pemitrem A (12) . It has been shown that 14 C-labelled ochratoxin A accumulates in pancreas after low dose intravenous injection (13, 14) . Berndt et al. found that repeated low doses given to rats produced accumulation of the toxin in susceptible tissues, which resulted in excessive weight loss and diarrhea, perhaps related to the impairment of exocrine pancreatic function (15) . However, although the toxicity of ochratoxin A is extensively studied, only limited attention has been directed toward changes produced in the pancreatic tissue. Therefore -we decided to study effects of ochratoxin A on the pancreas and especially on pancreatic plasma membranes.
The main goal of this study was to determine changes in the activities of enzymes bound to the pancreatic cell membrane, as a result of administration of repeated low doses of ochratoxin A (120 μg/kg body weight) during 20 and 35 days of treatment. This dose corresponds to an average in the feed of 1.5 mg/kg each day, a concentration that may be encountered in naturally contaminated food products (16) . However, in our previous work we observed changes in the activities of kidney brush border enzymes induced by a similar regimen of ochratoxin A treatment. Increased activities of rat renal brush border enzymes in urine were found when low doses of ochratoxin A were applied for 20 and 30 days (17) . The enzymes in this study were chosen as indicators for the stability of pancreatic cell membranes. The selected enzymes 
Materials and Methods

Materials
Ochratoxin A was obtained by biosynthesis from culture ofAspergilliis sulphureus NRRL 4077 on wheat kernels with 40% humidity. Isolation procedure was essentially according to 1. c. (18) . The white crystalline material was tested for .purity by thin-layer chromatography and then identified as abright blue fluorescent spot under short wave UV light (19) . The concentration of ochratoxin A was determined spectrophotometricaliy at 333 run in methanol, assuming a molar absorbance of 550 m 2 /mol (1).
Animals
Adult albino female rats of Fisher strain weighing between 150 and 200 g were used for the experiments. The animals were given food and water ad libitum, (food -standard laboratory pellets, declared not to contain mycotoxins, PLIVA d.d., Zagreb, Croatia). Rats were divided into experimental (n = 10) and control (n = 5) groups.
Group A -20 days treatment
Daily dose of ochratoxin A 120 μg/kg body weight (dissolved in a volume of 0.5 ml of 0.051 mmol/1 NaHCO 3 ) was administered to experimental animals each morning by gastric intubation. Animals were sacrificed after 20 days of treatment. Total amount of ochratoxin A given was 400 μg ochratoxin A per animal.
Group B -35 days treatment
The animals received the same daily dose during 35 days, corresponding to total amount of 720 μg ochratoxin A per animal.
Controls
The control animals received daily dose of 0.5 ml of 0.051 mmol/i for 20 and 35 days, respectively.
Isolation of pancreatic plasma membranes
Rats were sacrificed by cervical dislocation after light ether anesthesia. Pancreas was homogenized at 4 °C in an Ultra-turrax homogenizer in 5 mmol/1 Tris-Hepes buffer (pH 7.0), containing 280 mmol/1 mannitol, 10 mmol/1 KC1, 1 mmol/1 MgCl 2 , 1 mmol/1 benzamidine and 0.1 g/1 soybean trypsin inhibitor. The homogenates were centrifuged for 15 min at 1000 g and supernatant was further centrifuged at 13000g for 20 min. Pellets containing cell membranes were resuspended in 1 ml of the same buffer, vesiculated and centrifuged for 30 min at 18 000 g. The final pellet, containing plasma membranes was resuspended and vesiculated in 0.5 ml of the 500 mmol/1 Tris-Hepes buffer (pH 7.4) and saved for enzyme analysis. The analyses of the enzyme activity were performed with the fresh membrane preparations.
Enzyme assays
Determination of the activity of ecto-Ca Protein concentration was determined according to Bradford (24) using bovine serum albumin as a standard. Spectrophotometric measurements were performed on the Unicam SP 8 X 100 Spectrophotometer.
Chemicals
All biochemicals, including coenzymes, substrates and auxiliary enzymes were of analytical grade purchased from Sigma Chem. Co. (St Louis, Mo, USA), or Boehringer (Mannheim, Germany).
Statistics
The data are presented as mean values ± SEM.
Significance of the difference was tested by Mann-WIiitney U-test. Values were considered significantly different if p < 0.05.
Results
In this paper we studied the changes that occur in the pancreatic plasma membrane following 3-5 weeks of daily, oral application of low doses of ochratoxin A to rats. Activities of membrane bound ecto-Ca In the preliminary experiments we found detectable concentration of ochratoxin A in the pancreas following acute and prolonged treatment with low doses of the toxin. When inspected under UV light, pancreatic tissue showed fluorescence characteristic for the presence of ochratoxin A (results not shown). The serum level of ochratoxin A was measured according to Hult et al., and was found to be 300 μg/l following 35 days of treatment (1). Table 1 shows the effects of ochratoxin A on body weight, pancreas weight and protein content in pancreatic tissue. The experimental animals that were receiving daily doses of 120 μg/kg body weight of ochratoxin A during 35 days showed a significant decrease in the body weight gain of about 75% and decreased protein concentration in the homogenates prepared from the pancreatic tissue, in comparison to the control group. We suppose that the combination of the reduction in the food intake and inhibition of the protein synthesis might both be contributing to the effects measured.
Data concerning activities of the enzymes in the pancreatic plasma membrane are very scarce, therefore we first had to establish control values for the enzyme activities that would be used as the reference for the comparison. Table 2 represents the activities of: ecto-Ca 2+ /Mg 2+ -ATPase, ecto-5'-nucleotidase, alanine aminopeptidase, γ-glutamyl transferase and alkaline phosphatase in pancreatic plasma membrane of control animals. The activity of the enzymes tested did not significantly change between the two experimental time points.
Changes in the activities of the pancreatic membrane bound enzymes following 20 and 35 days of treatment, respectively, are shown in the figure 1. From the results presented, it is evident that ochratoxin A produced a Data are presented -as mean ± SEM from control (n = 5) and c Ochratoxin A treated animals received ochratoxin A at a daily treated (n = 10) animals.
dose of 120 μg/kg body weight dissolved in 0.5 ml of 0.051 mmol/1 a The gain in the body weight was measured for 20 and 35 days, NaHCO 3 , for the indicated number of days. respectively.
d Statistical significance of the difference between treated and conb Controls received 0.5 ml of 0.051 mmol/1 NaHCO 3 , daily. trol rats at the confidence level p < 0.05. -ATPase and alkaline phosphatase were reduced in comparison to the controls, and the fraction of the remaining activities were 0.76 ± 0.04, 0.53 ± 0.03 and 0.30 ± 0.02, respectively. Changes in the activities of γ-glutamyl transferase and 5'-nucleotidase were not statistically significant. In the prolonged course of treatment, following 35 days of ochratoxin A intoxication, only the activity of alanine aminopeptidase returned to control values. However, it is worth mentioning that 5'-nucleotidase, alanine aminopeptidase and γ-glutamyl transferase could be found in cytosolic and in membrane bound fractions in the cell (25) (26) (27) . The observed normalization may be a result of the novel redistribution of the enzyme isoforms between those two compartments. In contrast to these results catalytic concentration of ecto-Ca 2 +/Mg 2+ -ATPase and alkaline phosphatase remained significantly reduced at 0.56 ± 0.04 and 0.42 ± 0.03 of the control values, on day 35 of the experiment. It seems that normalization of catalytic concentrations of Ca 2+ /Mg 2 +-ATPase and alkaline phosphatase might require the synthesis of new protein molecules, a process that is seriously impaired by ochratoxin A treatment (5). Consequently, these enzyme activities remained significantly reduced. Similar results were observed in kidney (28, 29) .
Discussion
Biochemical changes that occur following treatment with ochratoxin A involve almost all organs and tissues. It has been well documented that toxin accumulates in the various tissues. Pharmacokinetic studies have shown that ochratoxin A is distributed in two kinetically distinct compartments in rats, the central compartment corresponding to well perfused organs such as kidney, liver, spleen, brain, lung, heart, pancreas and testes and a peripheral compartment comprising of skin, muscle, fat and eyes (13, 30) . The distribution pattern of ochratoxin A in the rats and mice was shown to be very similar (31) . A different response to ochratoxin A administration was observed when either a single or repeated doses were applied. Small doses injected repeatedly were required for the production of the severe changes in renal function, excessive weight loss and diarrhea. Deposition of toxin in the tissues was the consequence of the prolonged retention of ochratoxin A in the circulation, due to its binding to the plasma proteins (32) (33) (34) .
Accumulation of the toxin in pancreatic tissue has been shown to be connected with lowered insulin concentrations, possibly as a result of the toxin induced inhibition of synthesis and/or release of the hormone from -cells. The observed diabetogenic effects of ochratoxin A were attributed to the reduced level of glycolysis and glycogenesis and enhancement of gluconeogenesis and glycogenolysis (2).
In our previous studies we found that treatment with low doses of ochratoxin A over a period of 20 and 30 days affected activities of γ-glutamyl transferase, alanine aminopeptidase and alkaline phosphatase in kidney brush border membranes (17) . These time points were found to be informative for the subchronical regimen of treatment. It was shown by Kane et al. that activities of renal, membrane bound enzymes such as γ-glutamyl transferase, leucine aminopeptidase, and alkaline phosphatase were significantly reduced, following subchronical ochratoxin A treatment (28).
Since it has been shown that ochratoxin A accumulated in the pancreatic tissue, we followed the activity of the same enzymes in pancreas, repeating the low dosage regimen, which results in deposition of the toxin in susceptible tissues. We included measurement of the activity of ecto-Ca 2+ /Mg 2+ -ATPase and ecto-S'-nucleotidase in this study since these two membrane enzymes might be involved in the metabolism of extracellular ATP and possible regulation of the ATP-dependent Ca 2+ uptake in the pancreas. Calcium ions play an important role in the stimulation of enzyme secretion from exocrine pancreas. It has been proposed that a secretagogue-induced rise in cytosolic free Ca 2+ triggers enzyme release from pancreatic acinar cells (35, 36) . Activity of Ca 2 +/Mg
2+^A
TPase was shown to be involved in the exocytosis of the pancreatic enzymes from the membrane bound zymogen granules (37) . However, the exact physiological function of ecto-Ca 2+ /Mg 2+ -ATPase activity is not clear. It is assumed that it may simply serve to regulate extracellular ATP concentration in the vicinity of the plasma membrane (38) . As it has been shown for renal proximal tubule a concerted action of ecto-Ca 1 and fig. 1 ). The observed reductions in the enzyme activities might be reflecting the decrease in the DNA and protein synthesis that are produced by the ochratoxin A treatment (5, 39, 40) . Decrease of the enzyme activity could not be explained in terms of the mode of attachment to the cell membrane. Affected enzymes belong to groups that are bound to the membrane in different ways.
Leakage of enzymes from the damaged cell membrane is mainly influenced by the mode of attachment of the particular enzyme protein to the hydrophobic phospholipid membrane structure. The simplest form of attachment is exemplified by γ-glutamyl transferase and alanine aminopeptidase, in which the terminal sequence of hydrophobic amino acids is inserted into the membrane. There it is secured by hydrophobic interactions between the amino acids and the lipid components of the membrane. A more complex system refers to the attachment of ectoenzymes like S'-nucleotidase, Ca 2+ /Mg 2+ -ATPase and alkaline phosphatase. These enzymes are anchored in the membrane through the glycan phosphatidylinositol moiety that is linked to the carboxy terminus of the polypeptide chain. Release of the enzyme may be influenced either by detergent mediated solubilisation, by enzyme cleavage (protease or phospholipase), or by the fragmentation of the membrane structure (41).
Activity of alanine aminopeptidase was already significantly affected after 20 days, but it returned to higher than normal levels in the following 15 days, in spite of the continuation of the ochratoxin A treatment. That was a surprising finding since ochratoxin A treatment produces a decrease hi DNA and protein synthesis. Increased level of membrane bound alanine aminopeptidase might be originating from the cytosolic fraction. Acknowledgements However, γ-glutamyl transferase, bound to the membrane in a similar way, did not exhibit significant changes at the same time. From the group of more tightly bound enzymes only ecto-Ca 2+ /Mg 2+ -ATPase and alkaline phosphatase were significantly reduced while ecto-5'-nucleotidase remained unchanged.
In his recent review Moss showed that alkaline phosphatase could be released either by phospholipase action or by membrane fragmentation (42) . It was shown before that both γ-glutamyl transferase and 5 f -nucleotidase could be solubilized at increased amounts in cholestasis, presumably by a detergent-mediated action of bile acids. There are no reports that ochratoxin A treatment is associated with increased levels of bile acids in blood or liver, much less in the pancreatic tissue. The simplest explanation for the reduced level of the membrane bound enzyme activities observed in this study is a possible alteration of membrane lipid organization and potential membrane fragmentation. Perturbation of the liver microsomal membranes has been attributed to ochratoxin A induced increased NADPH-dependent lipid peroxidation (29) . In order to gain further insight into the effects of ochratoxin A an human and animal health in more detail, the influence of repeated low doses on the endocrine and exocrine function of the pancreatic cells must be further investigated.
Conclusions
The observed decrease in the catalytic concentration of the membrane bound enzymes measured suggests that ochratoxin A is connected with an impairment in the structure and function of the pancreatic plasma membrane. Acute effects reflected in the reduction of the enzyme activities could be subsequently normalized for alanine aminopeptidase in spite of the continuation of the daily ochratoxin A treatment. However, reduction in the activities of the Ca 2+ /Mg 2 " l "-ATPase and alkaline phosphatase remained unchanged. From the above observations we conclude that ochratoxin A exerts its toxic effects on pancreas by diminishing catalytic concentrations of the membrane bound enzymes, most probably by inducing the release of the enzymes as a result of the impairment of the functional integrity of the cell membrane.
